The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Follow-up: Evidence quality in the secretagogue literature: an honest assessment

This is a generated summary. It shows the 5 most-liked posts from a topic of 25, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
BS
buffer_sheetTL3Regular23 Nov 2025#1

On the subject in the title: Evidence quality in the secretagogue literature: an honest assessment Working notes rather than a conclusion.

A follow-up question about Evidence quality that I did not know to ask the first time.

The earlier thread answered what I asked. What I should have asked is below, and I think it is the one that matters.

34 likes 8mo
CI
c.inglethorpeTL3Regular27 Dec 2025#5

Post #2 answers the question as asked. The question underneath it is different.

The most useful thing anyone has posted about Evidence quality in this category was a table of what had been measured and by whom. That is what I would want again.

25 likes 7mo
PK
p.krastevTL216 Feb 2026#14
m.nwosu, post #4: The opening post put the caveat in the right place and I want to underline it. What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength as secondary outcomes, adequate follow-up duration. Very few secretagogue trials meet that… Go to post

Evidence quality is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.

27 likes in reply to #4 5mo
I
IHollingworthTL2Member13 Mar 2026#19

I would put moderate confidence on the mainstream reading of Evidence quality and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.

26 likes 5mo
EP
e.piresTL25 Apr 2026#24

Answering the question post #23 raises rather than the one it answers.

Published human data on most of this family is thin, old, or from small studies with surrogate endpoints. That is a genuine limitation and it is the honest answer to most questions in this subcategory.

26 likes 4mo

Read the full topic (25 posts)

Promoted into the documentation commons. The content of this topic is maintained at Ipamorelin — reference, with named maintainers and a review date. The promotion was discussed in doc review. Corrections are best raised against the document, which is the version that gets kept current.

Suggested topics

TopicParticipantsRepliesViewsActivity
About the Secretagogues & GH axis category
Growth-hormone secretagogues and related compounds. Evidence quality here is markedly lower and we say so. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
KBNNHVSCN+6 10 1.1k 14mo
Tesamorelin has an approved indication — what that changes about the evidence
Tesamorelin has an approved indication — what that changes about the evidence — setting out what I have, and where I think it stops being reliable. What changes if the standard account of tesamorelin is…
FHPMOONBPW+23 27 3.4k 1d
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence
Posting this under the heading it deserves: Tesamorelin has an approved indication — what that changes about the evidence Everything below is what sits behind that. What changes if the standard account of…
RLHFTDIBBW+63 68 18k 14mo
[2026 update] Evidence quality in the secretagogue literature: an honest assessment
Posting this under the heading it deserves: Evidence quality in the secretagogue literature: an honest assessment Everything below is what sits behind that. I have spent a fortnight trying to pin Evidence…
SDSSHKLFES+14 18 3.1k 6mo
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Writing it up because I had to work it out twice and would rather nobody else did. GHRH analogues versus ghrelin mimetics — I…
BNGRKRZSHM+9 13 249 17mo

Related topics — sharing the tags CJC-1295, ipamorelin, tesamorelin

TopicParticipantsRepliesViewsActivity
Revisiting: What a well-designed human trial of a secretagogue would look like
On the subject in the title: Revisiting: What a well-designed human trial of a secretagogue would look like Working notes rather than a conclusion. Something about well-designed human trial does not reconcile…
HBSBOIDAS+69 74 25k 18mo
Warfarin and altered intake: the monitoring argument — the long version
Posting this under the heading it deserves: Warfarin and altered intake: the monitoring argument — the long version Everything below is what sits behind that. A narrow question about Warfarin and altered…
BSBGRMPMO+123 134 40k 4mo
Revisiting: Oral versus injected administration claims for BPC-157
On the subject in the title: Revisiting: Oral versus injected administration claims for BPC-157 Working notes rather than a conclusion. A follow-up question about Oral versus injected administration claims…
IGAAILRILD+23 27 7.7k 15mo
When "no data" is the complete and final answer
Asking directly, because I could not find a straight answer: When "no data" is the complete and final answer Asking about the compound itself rather than about a trial of it. I have read the maintained page…
NPNTPOSPNS+154 165 6.3k 15mo
Delayed gastric emptying and oral medication absorption: which drugs matter
On the subject in the title: Delayed gastric emptying and oral medication absorption: which drugs matter Working notes rather than a conclusion. A follow-up question about delayed gastric emptying and oral…
RGSGIIIAGT+110 116 43k 14mo